NCT00660595View on ClinicalTrials.gov

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

PHASE3TerminatedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Schizophrenic Disorders

Interventions

DRUG

Quetiapine

Oral administration

DRUG

Risperidone

Oral administration

Trial Locations (4)

Unknown

Research Site, Harjavalta

Research Site, Helsinki

Research Site, Pitkäniemi

Research Site, Turku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY